Free Trial

GeneDx (WGS) Insider Trading & Ownership

GeneDx logo
$78.71 +6.64 (+9.21%)
(As of 11/22/2024 ET)

GeneDx (NASDAQ:WGS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
27.30%
Number Of
Insiders Buying
(Last 12 Months)
5
Amount Of
Insider Buying
(Last 12 Months)
$4.12 M
Number Of
Insiders Selling
(Last 12 Months)
20
Amount Of
Insider Selling
(Last 12 Months)
$105.70 M
Get WGS Insider Trade Alerts

Want to know when executives and insiders are buying or selling GeneDx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

WGS Insider Buying and Selling by Quarter

GeneDx Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/19/2024Jason RyanDirectorSell31,510$71.28$2,246,032.80  
11/18/2024Katherine StuelandCEOSell22,307$70.34$1,569,074.38  
11/18/2024School Of Medicine At Mo IcahnMajor ShareholderSell126,782$70.78$8,973,629.96  
11/15/2024Katherine StuelandCEOSell23,108$70.48$1,628,651.84  
11/15/2024School Of Medicine At Mo IcahnMajor ShareholderSell20,359$69.78$1,420,651.02  
10/31/2024School Of Medicine At Mo IcahnMajor ShareholderSell865,800$75.00$64,935,000.00  
50-year Wall Street legend: “Sell this tech stock NOW” (Ad)

Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.

You can watch for it for free, right here.
10/29/2024Katherine StuelandCEOSell2,154$66.60$143,456.40  
10/29/2024Kevin FeeleyCFOSell274$66.60$18,248.40  
9/9/2024Katherine StuelandCEOSell3,639$33.33$121,287.87  
9/9/2024Kevin FeeleyCFOSell895$33.33$29,830.35  
9/3/2024Kevin FeeleyCFOSell262$31.71$8,308.02  
8/19/2024Opko Health, Inc.Major ShareholderSell50,000$34.49$1,724,500.00  
8/15/2024Opko Health, Inc.Major ShareholderSell39,824$33.08$1,317,377.92  
8/12/2024Opko Health, Inc.Major ShareholderSell59,787$33.95$2,029,768.65  
8/8/2024Opko Health, Inc.Major ShareholderSell100,000$31.82$3,182,000.00  
8/6/2024Opko Health, Inc.Major ShareholderSell12,994$29.35$381,373.90  
7/31/2024Opko Health, Inc.Major ShareholderSell88,839$33.50$2,976,106.50  
7/29/2024Katherine StuelandCEOSell2,154$33.54$72,245.16  
7/29/2024Kevin FeeleyCFOSell274$33.54$9,189.96  
7/29/2024Opko Health, Inc.Major ShareholderSell50,000$33.86$1,693,000.00  
7/26/2024Opko Health, Inc.Major ShareholderSell60,000$33.85$2,031,000.00  
7/24/2024Opko Health, Inc.Major ShareholderSell75,000$33.72$2,529,000.00  
7/22/2024Opko Health, Inc.Major ShareholderSell50,000$32.61$1,630,500.00  
7/19/2024Opko Health, Inc.Major ShareholderSell25,000$32.29$807,250.00  
7/17/2024Opko Health, Inc.Major ShareholderSell25,000$32.93$823,250.00  
7/5/2024Opko Health, Inc.Major ShareholderSell36,118$28.24$1,019,972.32  
7/3/2024Opko Health, Inc.Major ShareholderSell14,082$28.23$397,534.86  
7/1/2024Opko Health, Inc.Major ShareholderSell50,000$26.63$1,331,500.00  
6/17/2024Katherine StuelandCEOSell7,683$28.31$217,505.73  
6/17/2024Kevin FeeleyCFOSell2,646$28.31$74,908.26  
6/10/2024Katherine StuelandCEOSell2,652$24.92$66,087.84  
6/10/2024Kevin FeeleyCFOSell895$24.92$22,303.40  
6/3/2024Casdin Capital, LlcDirectorBuy100,000$20.82$2,082,000.00  
5/28/2024Casdin Capital, LlcDirectorBuy18,304$20.61$377,245.44  
5/23/2024Casdin Capital, LlcDirectorBuy7,500$19.59$146,925.00  
5/13/2024Casdin Capital, LlcDirectorBuy50,000$23.31$1,165,500.00  
4/29/2024Katherine StuelandCEOSell6,325$11.04$69,828.00  
4/29/2024Kevin FeeleyCFOSell1,104$11.04$12,188.16  
3/18/2024Kareem SaadInsiderSell2,008$10.59$21,264.72  
3/18/2024Katherine StuelandCEOSell8,559$10.59$90,639.81  
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin
3/18/2024Kevin FeeleyCFOSell3,253$10.59$34,449.27  
3/4/2024Casdin Capital, LlcDirectorBuy40,000$8.74$349,600.00  
1/22/2024Kareem SaadInsiderSell193$3.24$625.32  
1/3/2024Kareem SaadInsiderSell105$2.58$270.90  
12/18/2023Kareem SaadInsiderSell1,700$2.16$3,672.00  
12/18/2023Katherine StuelandCEOSell11,734$2.16$25,345.44  
12/18/2023Kevin FeeleyCFOSell2,948$2.16$6,367.68  
12/4/2023Kevin FeeleyCFOSell270$1.77$477.90  
(Data available from 1/1/2013 forward)

WGS Insider Trading Activity - Frequently Asked Questions

The list of insiders at GeneDx includes Anthony Prentice, Casdin Capital, Llc, Daniel Emmett Clark, Eric Schadt, Isaac Ro, Jason Ryan, Kareem Saad, Karen Ann White, Katherine Stueland, Keith A Meister, Kevin Feeley, Opko Health, Inc., Richard C Pfenniger Jr, Richard Miao, School Of Medicine At Mo Icahn, Shawn Assad, and Tactical Opportunit Blackstone. Learn more on insiders at WGS.

27.30% of GeneDx stock is owned by insiders. Learn more on WGS's insider holdings.

The following insiders have purchased WGS shares in the last 24 months: Casdin Capital, Llc ($4,121,270.44), Jason Ryan ($72,062.34), Katherine Stueland ($99,988.02), and Richard C Pfenniger Jr ($69,900.00).

Insiders have purchased a total of 298,157 WGS shares in the last 24 months for a total of $4,363,220.80 bought.

The following insiders have sold WGS shares in the last 24 months: Jason Ryan ($2,246,166.78), Kareem Saad ($40,107.60), Karen Ann White ($29,346.88), Katherine Stueland ($4,219,100.26), Keith A Meister ($2,715,741.60), Kevin Feeley ($282,910.97), Opko Health, Inc. ($23,874,134.15), and School Of Medicine At Mo Icahn ($75,329,280.98).

Insiders have sold a total of 2,146,774 GeneDx shares in the last 24 months for a total of $108,736,789.22 sold.

GeneDx Key Executives

  • Ms. Katherine A. Stueland (Age 48)
    President, CEO & Director
    Compensation: $745.91k
    7 recent trades
  • Mr. Kevin Feeley (Age 43)
    Chief Financial Officer
    Compensation: $488.19k
    6 recent trades
  • Ms. Karen Ponchner
    Senior VP & Head of Operations
  • Mr. Eric Olivares Ph.D.
    Chief Product & Technology Officer
  • Mr. Devin K. Schaffer J.D.
    M.B.A., General Counsel
  • Mr. Paul Kruszka M.D.
    Chief Medical Officer
  • Ms. Melanie Duquette
    Chief Growth Officer
  • Sabrina Dunbar
    Chief of Staff


This page (NASDAQ:WGS) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners